• 1. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Aminosaccharides
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Aminosaccharides
• Other Chemical Reagents

Geneticin: A Comprehensive Overview of CAS No. 108321-42-2 in Modern Biomedical Research

Geneticin, chemically identified by the CAS number 108321-42-2, is a compound of significant interest in the field of biomedical research. This nucleoside analog has garnered attention for its multifaceted applications, particularly in the realms of genetic engineering, cell biology, and pharmaceutical development. The unique structural and functional properties of Geneticin make it a valuable tool for researchers exploring the intricacies of cellular mechanisms and therapeutic interventions.

The molecular structure of Geneticin is characterized by its nucleoside backbone, which incorporates a modified sugar moiety. This modification imparts distinctive biochemical properties, enabling Geneticin to interfere with essential cellular processes. Specifically, Geneticin functions as an inhibitor of protein synthesis by binding to the 28S ribosomal subunit, thereby halting the elongation phase of translation. This mechanism has been exploited in various experimental settings to study the consequences of impaired protein synthesis and to develop strategies for enhancing cellular resilience.

In recent years, Geneticin has been extensively utilized in gene editing and cell culture applications. Its ability to selectively induce apoptosis in mammalian cells has made it a cornerstone in the development of screening assays for drug candidates and in the study of apoptosis-related signaling pathways. Furthermore, Geneticin's role as a selective agent against certain mammalian cells has been leveraged in the production of hybridomas and other monoclonal antibody-producing cell lines. These applications underscore the compound's versatility and its importance in advancing biomedical research.

The therapeutic potential of Geneticin has also been explored in the context of cancer research. Studies have demonstrated that Geneticin can induce programmed cell death in cancerous cells while sparing healthy tissues, suggesting its potential as a targeted therapeutic agent. While further research is needed to fully elucidate its clinical applicability, these findings highlight the compound's promise in oncology. Additionally, Geneticin has been investigated for its antimicrobial properties, although its primary focus remains within mammalian cell culture systems.

Advances in synthetic chemistry have enabled the development of modified derivatives of Geneticin, each with tailored biological activities. These derivatives offer researchers a spectrum of tools for investigating specific aspects of cellular physiology and pathology. For instance, modifications aimed at enhancing solubility or stability have expanded the compound's utility in high-throughput screening platforms. Similarly, alterations to the nucleoside moiety have yielded analogs with altered toxicological profiles, facilitating safer and more efficient experimental protocols.

The integration of Geneticin into high-resolution imaging techniques has opened new avenues for visualizing cellular processes at a molecular level. By conjugating Geneticin with fluorescent tags or other imaging probes, researchers can track protein synthesis dynamics in real-time within living cells. This approach has provided invaluable insights into the spatial and temporal regulation of gene expression and protein assembly. Such advancements not only enhance our understanding of fundamental biological mechanisms but also contribute to the development of novel diagnostic tools.

The regulatory landscape surrounding Geneticin reflects its significance in biomedical research. Agencies such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have established guidelines for its use in laboratory settings to ensure safety and efficacy. These regulations emphasize proper handling procedures, waste disposal protocols, and ethical considerations when employing Geneticin in research involving human or animal cells. Compliance with these standards is essential for maintaining high-quality research outcomes and upholding ethical research practices.

The future prospects for Geneticin are promising, with ongoing studies exploring its role in regenerative medicine and neurobiology. Researchers are investigating its potential as a neuroprotective agent, leveraging its ability to modulate protein synthesis in neuronal cells. Additionally, efforts are underway to optimize Geneticin-based therapies for treating neurodegenerative disorders by enhancing delivery systems and minimizing off-target effects. These endeavors highlight the enduring relevance of Geneticin as a cornerstone compound in biomedical innovation.

• 1405-41-0(Gentamicin sulfate)
• 41194-16-5(Apramycin Sulfate)
• 26098-04-4(D-Streptamine,O-3-deoxy-4-C-methyl-3-(methylamino)-b-L-)
• 65710-07-8(Apramycin sulfate)
• 66803-19-8(Micronomicin Sulfate)
• 52093-21-7(Micronomicin)
• 49863-47-0(D-Streptamine,O-2-amino-2,7-dideoxy-D-glycero-a-D-gluco-heptopyranosyl-(1®4)-O-[3-deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1®6)]-2-deoxy-)
• 36889-17-5(D-Streptamine,O-2-amino-2-deoxy-a-D-glucopyranosyl-(1®4)-O-[3-deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1®6)]-2-deoxy-)
• 25876-11-3(D-Streptamine,O-3-deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1®6)-O-[2,6-diamino-2,3,4,6,7-pentadeoxy-a-D-ribo-heptopyranosyl-(1®4)]-2-deoxy-)
• 51846-97-0(D-Streptamine,O-3-deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1®6)-O-[2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl-(1®4)]-2-deoxy-)